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ABSTRACT 
Objective: The purpose of the present study was to functionalized graphene (f-GE) grafted chitosan (CS)/Polyaniline (PANI) with 
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(MMT) was different feed ratio known as f-GE-g-(CS/MMT-PANI).  
Methods: The prepared f-GE-g-(CS/MMT-PANI) was formulated using the solvent casting method. The prepared nanocomposites were 
characterized by X-Ray Diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), Scanning electron microscope (SEM), 
Thermogravimetric analysis (TGA), thermogravimetric (DTG) and swelling in stimulated in the different biological fluid. The model drug 
Doxorubicin (DOX) was used for controlled drug delivery purpose.  
Results: From FTIR result was clearly demonstrated that the model drug DOX did not change in any molecular level at f-GE-(CS/MMT-PANI) (i.e. 
at<10 nm scale). Additionally, in DSC result, DOX was interacted with nanocomposites at scale>100 nm level. With CS as the carrier, 60% of the drug 
was released in SIF for the initial 120 min and this increased to 80–82% with f-GE-g-CS/MMT/PANI matrix. But in SGF, CS as the carrier, 46% of the 
drug was released in 140 min and this increased to 78% with f-GE-g-CS/MMT/PANI. In vitro drug release system was carried out by Korsmeyer 
Peppas’s power law. DOX and other drugs like Doxorubicin (DOX) was presented an exceptional higher drug result in different pH medium.  
Conclusion: It was observed that CS/MMT was decreasing less drug release rate compared to f-GE-g-(CS/MMT-PANI). So that it can be clearly 
understood that f-GE-g-(CS/MMT-PANI) grafted nanocomposites have enhanced drug release activity in different pH medium.  




Chitosan (CS) is a biopolymer which is used for different purpose like 
biomedical, cosmetics, pharmaceutical products etc. It is very popular in 
pharmaceutical and medical filed for its unique properties like 
biodegradable, non-toxic, biocompatible, antimicrobial activities etc. In 
the present research, it is used for drug delivery applications [1]. Most of 
the scientific research publications have been proved; CS can be used for 
oral drug delivery purpose. But its poor physical properties such as 
brittleness, poor solubility require improvement for more medical 
application particular in drug delivery field as carrier matrix. Many 
researchers have been reported that in chemical and biochemical routes 
will be possible to improve the expected properties. Among grafting 
procedure, it is easy to prepare and synthesis of modified chitosan 
polymer composites with biodegrable nature for different purpose [2].  
The functionalized graphene acts as efficient nanofiller in polymer 
composites to improve its engineering properties and a small quantity 
of polymer functionalized graphene improve the mechanical, 
electronic, optical, thermal and magnetic properties significantly. The 
living radical polymerizations on graphene surface can also produce 
diverse polymeric architecture promoting graphene from a laboratory 
to important nanotechnological applications.  
Chitosan nanocomposites have been well studied for drug delivery 
and other applications using MMT nanoclay. But limited studies have 
been made on chitosan grafted onto graphene for drug delivery 
purpose [2-6]. Generally the hydrophobicity and hydrophilicity 
nature of polymer is contributing a lot in controlling the drug release 
characteristics apart from its flexibility [7-10]. However, this 
experiment is focused on the preparation of chitosan 
nanocomposites grafted with graphene for controlled drug release 
of anticancer drug DOX in different pH medium.  
In the present work, GE grafted CS/MMT-PANI to evaluate the 
feasibility of loading and release of DOX drug with applicable 
efficiency and to elucidate the effect of biopolymer addition and 
MMT clay addition on the rate of DOX drug release. 
MATERIALS AND METHODS 
Materials  
Chitosan (Mw = 110 kDa, deacetylation degree>90%) and graphene 
(GE) were obtained Himedia. Polyaniline, MMT and Doxorubicin 
(DOX) was purchased from sigma, India. All other chemicals used 
were of analytical grade which were commercially available.  
Preparation of CH/MMT nanocomposites 
Chitosan was dissolved in 2% v/v aqueous glacial acetic acid at a 
concentration of 2 Wt%. The prepared solution samples were 
subjected to centrifuging at 2000 rpm to remove the insoluble residual 
material [11]. In addition, MMT was swelled in 50 ml distilled water by 
magnetic stirring for 60 min at 30±1 °C. Then the prepared chitosan 
solution with chitosan/MMT Wt ratio of 1/1, 1/2 and 2/1, followed by 
stirring for 4 h under different temperature (40 °, 50 °, 60 ° and 70 °C.) 
Then, PANI (2% wt, respect to the solid concentration of matrix) was 
dispersed in an acetic acid solution (1% v/v) for 24 h and further 
treated by ultrasonication (Bandelin D-12,207, Germany) and added 
into polymeric suspension under agitation for 6 h. After that CS/MMT-
PANI solutions were filtered and dried by vacuum at 70 °C for 48 h.  
Synthesis of GE grafted with f-GE-g-(CS/MMT-PANI)  
The GE-g-CS/MMT was prepared by the following procedure. 
CS/MMT-PANI was prepared in 1% (v/v) acetic acid. The prepared 
solution of GE (5.0 g) was added into nanocomposites (CS/MMT-
PANI). The reaction mixture of solution was refluxed at 100 °C for 12 
h and dialyzed with distilled water. Then the mixture of solution was 
lyophilized for preparation of f-GE-g-(CS/MMT-PANI) powder [11].  
Preparation of DOX drug-loaded f-GE-g-CS/MMT (f-GE-g-
CS/MMT-DOX)  
Different masses of DOX (0.05, 0.1, 0.15 and 0.2 g) were dissolved 
with f-GE-g-CS/MMT-DOX sample, which was prepared under the 
optimum conditions of temperature and concentrations [12]. The 
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mixture was subjected to a magnetic stirring at different reaction 
temperatures (40 °C, 50 °C, 60 °C and 70 °C) for different times (0.5, 
1, 2 and 4 h) to affect cross-linking. 
Characterization  
Fourier transforms infrared (FTIR spectra) 
The FTIR spectra were demonstrated on a Nicolet 8700 
spectrometer, in the absorbance range in between 400–4,000 cm-1
This study was performed in both simulated gastric Fluid (SGF) and 
(simulated intestinal fluid (SIF) in phosphate buffer (PBS) at 37 °C 
on copolymer pellets (100 mg, 2.55 mm thickness and 13 mm 
diameter). The sample was 25 mm diameter; 50 mm height which 
was immersed 20 ml phosphate buffer. The weights of the swelled 
sample at predetermined time intervals were calculated after wiping 
the mesh containing the swelled polymer with a tissue paper. Then a 
graph was drawn between the degree of swelling (= (W
. 
X-ray diffraction (XRD) 
XRD instrument Rigaku, D/Max, 2,500 V, Cu-αa radiation: 1.54056A 
° was used for an experiment. The result was recorded at a 
temperature of 30 °C. 
Scanning electron microscopy (SEM) 
SEM of nanocomposites was demonstrated by S 4300 Hitachi, 
Illinois, USA. The prepared sample was placed into a specimen 
holder with a silver plate coated by palladium. At analysis time the 
accelerator potential was 10kV.  
Tharmogravity analysis (TGA) 
TGA was performed on a thermal analyser (TA Instruments, SDT 




and time, where Wt and W0
In vitro drug dissolution study 
 are the weights of the sample after and 
before swelling, respectively. 
In vitro drug dissolution study was made by Veego Model in SGF and SIF 
at room temperature with 500 RPM. The amount of model drug released 
was estimated by UV spectrophotometer in the different time interval. 
The absorbance of pure DOX drug was calculated to be 254 nm.  
Statistical analysis  
The experimental data are measured by one-way analysis of 
variance (ANOVA). All data analysis was executed using the SPSS 
Statistics 17.0. All experimental data were introduced as a mean 
value with its standard deviation (mean±SD). P-values less than 0.05 
were recommended to be statistically significant.  
RESULT AND DISCUSSION  
As shown in fig. 1(a,b) chitosan was first reacted with MMT and 
PANI in the presence of acetic acid to functionalize partial amino 
groups of the CS/MMT-PANI. Then CS/MMT-PANI was reacted with 
f-GE in the presence of acetic acid to functionalize partial amino 
groups of the chitosan with f-GE and obtained f-GE-g-(CS/MMT-




Fig. 1: Schematically representation of f-GE grafted CS/MMT-PANI nanocomposites for controlled release of anticancer drug DOX (a); 
sturucture of Doxorubicin (b) 
Roy et al. 




Fig. 2 showed FTIR of pure CS, a broad-OH stretch absorption band 
between 3500 and 3100 cm−1 and the aliphatic C-H stretch between 
2345 and 3312 cm−1. The peak at 1505 cm−1 represented the-C-O 
stretch of the primary alcoholic group (-CH2
CS/MMT-PANI, the broad peak at 3449 cm
-OH) [13].  
−1 (interlayer and interlayer 
H-bonding upon stretching), 3425 cm−1(O-H stretching), 2413 cm−1(O-
H bending), 943–560 cm−1 (Si-O bending vibrations), 1132 cm−1 (Si-O 
stretching vibrations). At 1534 cm−1
The f-GE-g-CS/MMT/PANI showed both patterns of CS/MMT and GE. 
The expected peaks of the chitosan backbone was at 3449 cm
 (protonated amine group) of CH is 
transformed towards the lower frequency value which indicated an 
electrostatic interaction between an amino group of CS and the 
negatively charged sites in the MMT structure [14]. 
−1 and 
2365 cm−1 (-OH stretching and-C-O stretching), respectively. 
Further, the absorption peak of the GE vibration of CS at 884.9 cm−1 
and the characteristic peak of GE at 967 cm−1
 
Fig. 2: FTIR of CS, DOX, MMT, CS/MMT-PANI, f-GE-g-CS/MMT, DOX-f-GE-g-CS/MMT 




Fig. 3 showed XRD of pure CS, a characteristic peak at 2θ = 18.95 ° 
and MMT shows a peak at 2θ = 8.54 ° in fig. 2b [13]. XRD spectra of f-
GE-CS and f-GE-CS/MMT-PANI showed broad single peak pattern at 
2θ values of 19 °, 25 °, 37 °, 43 ° and 45 ° respectively, indicating 
crystallinity and considerably more crystalline than chitosan. It can 
be hypothesized that the increase crystallinity of f-GE-g-CS and f-GE-
g-CS/MMT is due to deformation of the strong bonds in the chitosan 
backbone as the amino groups are functionalized by f-GE [14]. 
  
 
Fig. 3: XRD of CS, DOX, MMT, CS/MMT, f-GE-g-CS/MMT, DOX-f-GE-g-CS/MMT 
 
SEM  
As shown in fig. 4, f-CS/MMT-PANI a nanocomposite was studied by 
SEM. CS was intercalated structures present due to the interaction of 
MMT nanoclay and PANI within the polymer composite. The 
intercalated structure was found in GE-g-CS/MMT-PANI 
nanocomposites due to the electrostatic interaction of f-GE and 
CS/MMT-PANI, respectively.  
Roy et al. 








Fig. 5a: TGA of CS, CS/MMT and f-GE-g-CS/MMT, b: TG traces of 
CS, CS/MMT-PANI and GE-g-CS/MMT-PANI 
 
TG and DTG  
TG and DTG thermograms of CS and f-GE-g-CS/MMT-PANI recorded 
in nitrogen atmosphere are displayed in fig. 5a and b, respectively. 
The weight losses around 100 ° C in CS and f-GE-g-CS/MMT-PANI 
are assigned to loss of volatile impurities and moisture. The TG/DTG 
of graft copolymer displayed three step degradation in the 
temperature range between 150 °–900 °c. The weight loss in the 
temperature range 200 °–500 ° C with maximum weight loss around 
273 ° C (51.34%) is attributed to chitosan backbone degradation 
[14]. The weight loss around 171 ° C is more likely to be attributed 
to degradation of f-GE fragment on the CS backbone with terminal 
double bonds. The weight losses observed around 273 ° and 381 ° C 
are due to onset degradations of CS moiety, and poly CS residue with 
saturated terminal ends and CS moiety, respectively. A degradation 
step noticed around 387 ° C in CS not seen in the copolymer and the 
observed residual weights of 7.1% and 1.3% at 820 ° C in the TG 
traces of CS and CS and f-GE-g-CS/MMT, respectively, collectively 
reveals that the graft copolymer with a decreased thermal stability 
degrades faster compared to CS. This was also corroborated by the 
residual mass of 7.1% at 820 ° C in the TG traces of the polymer 
blend of CS and f-GE-g-CS/MMT (fig. 5a and b). The degradation 
behavior of the blend, CS and the graft copolymer are quite different 
indicating that the TG traces of graft copolymer displayed is not a 
physical mixture of CS and the homopolymers. Different thermal 
degradation behavior of the graft copolymer compared to that of the 
blend also revealed that the grafting had occurred [16, 17]. 
Solubility study  
Fig. 7 exhibited the transmittance of f-GE-g-CS/MMT-PANI in water 
with various pH compared with chitosan and GE-g-CS at 5 mg/ml. It 
was found out that the water solubility of CS, f-GE-g-CS and f-GE-g-
CS/MMT decreased with the increase of pH. CS, f-GE-g-CS, f-GE-g-
CS/MMT showed excellent water solubility at low pH due to 
protonation of amino groups. At the pH range of 4.0–9.0, the f-GE-g-
CS/MMT showed better water solubility than chitosan and f-GE-g-
CS, which indicated enhances the solubility of chitosan.  
 
 
Fig. 7: Solubility study of CS, CS/MMT, CS-g-GE, GE-g-CS/MMT; 




Fig. 8: Degree of swelling of graft copolymer in SGF (a) and SIF 
(b) at 37 ° C; n=3 and data are given in mean±SD 
Roy et al. 
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In vitro swelling studies  
To evaluate this effect, swelling studies were carried out with 
CS/MMT-PANI and f-GE-g-CS/MMT-PANI in SGF and SIF at 37 °C 
[15]. The degree of swelling in SGF and SIF for f-GE-g-CS/MMT-PANI 
polymers prepared with increasing concentrations of is given in fig. 
8a and b. The degree of swelling was significantly different in SIF 
and SGF for a matrix of the typical composition. In SIF, the rate of 
swelling is more than that in SGF, and it attains the equilibrium 
value within 45 min. But in SGF the equilibrium swelling rate was 
attained only after 160 min. The greater extent of swelling in SIF 
compared to that in SGF may be more likely due to enhanced 
hydrogen bonding between GE-g-CS/MMT and SIF through the 
formation of carboxylate anion (–COO). 
Dissolution study  
F-GE-g-CS/MMT matrices were synthesized with various 
concentrations of f-GE in the feed. Both in SIF and SGF the drug 
release rate was greater for pure CS than that observed for grafted 
CS/MMT-PANI [15]. This was attributed to the burst release of the 
drugs due to tablet breaking after immersing in biofluids. For the 
same drug, the release rate is more in SIF than in SGF (fig. 9a). This is 
more likely attributed to the greater degree of swelling of the matrix 
in SIF than in SGF. But grafting decreased the drug release in both 
the fluids. This is more likely attributed to the enhanced drug-
polymer interaction through H-bonding between–COOH and–OH 
groups of f-GE-g-CS/MMT and–OH group of the drug as supported by 
DSC (fig. 6). With CS as carrier, 60% of the drug was released in SIF 
for the initial 120 min and this increased to 80–82% with f-GE-g-
CS/MMT/PANI matrix. But in SGF, CS as the carrier, 46% of the drug 
was released in 140 min and this increased to 78% with f-GE-g-
CS/MMT/PANI. 
Drug release mechanism  
To understand and analyze the mechanism of in vitro drug release 




Where Mt/M∞ is the fractional release of drug at time‘t’ or fractional 
uptake of fluid in swelling in the absence of drug (Mt/M∞, amounts of 
model drug released at the time ‘t’ respectively) was used. The release 
mechanism of the drug was explained by Peppas equation. The slope 
of the linear plot log Mt/M∞
 
 versus log t, for drug release<50% gives 
the power law exponent (n) value. The equation n = 0.5 (diffusion-
Fickian controlled drug release) and n = 1 (swelling-controlled drug 
release or non-Fickian) where is ‘n’ anomalous transport kinetics. The 
observed ‘n’ values for typical release profiles of DOX were<0.5,>0.5 
and>1.0. These ranges of ‘n’ values indicate a combined mechanism of 
pure diffusion and non-Fickian for the drug release with the grafted 
GE-g-CS/MMT/PANI matrix both in SGF and SIF. 
 
 
Fig. 9: Release profiles of model drug DOX in SIF (a) and SGF (b) 
at 37 °C, with graft copolymer carriers CS, CS/MMT, CS-g-GE, GE-
g-CS/MMT/PANI; n=3 and data are given in mean±SD 
  
Table 1: Release kinetic parameters of films of DOX (n=3) 
Sample Korsmeyer peppas 
r n 2 
CS 0.9761 0.4131 
CS/MMT 0.9831 0.4221 
CS-g-GE 0.9758 0.5143 
GE-g-CS/MMT/PANI 0.9956 0.6152 
*
 
CS molecular weight in kDa. n=3 and data are given in mean±SD, Where CS: Chitosan, GE: Graphene, PANI: Polyaniline, MMT: Montmorilonite, DOX: 
Doxorubicin 
CONCLUSION 
The nanocomposites f-GE-g-CS/MMT has been synthesized and 
characterized for controlled released of DOX for oral drug delivery. 
The drug release rate was greater in SIF than in SGF due to enhanced 
matrix swelling in SIF and lower with f-GE-g-CS/MMT carrier 
compared to CH. In SGF the initial drug release rate was sluggish but 
started increasing rapidly after 120 min due to increased segmental 
mobility. Increasing the concentration of f-GE in the feed enhanced 
the drug release rate with the corresponding grafted CS as a carrier 
due to enhanced polymer–biofluid interaction.  
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